Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis

Cornea

Volumn 32, Issue 4, 2013, Pages 445-449

  Ramakrishnan, Thushanthi ^a   Constantinou, Marios ^b   Jhanji, Vishal ^b   Vajpayee, Rasik B ^a,b  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

fungal keratitis; management; outcomes; voriconazole

Indexed keywords

AMPHOTERICIN B; NATAMYCIN; OFLOXACIN; VORICONAZOLE;

ACANTHAMOEBA; ADULT; AGED; BACTERIAL KERATITIS; CANDIDA; CLINICAL ARTICLE; CONTROLLED STUDY; CORNEA PERFORATION; DISEASE COURSE; ENUCLEATION; FEMALE; FUNGUS CULTURE; FUSARIUM; HERPES SIMPLEX VIRUS; HUMAN; HUMAN TISSUE; HYPOPYON; KERATOMYCOSIS; LOADING DRUG DOSE; MALE; MEDICAL RECORD REVIEW; MIXED INFECTION; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; SLIT LAMP; STAPHYLOCOCCUS; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CANDIDA; EYE INFECTIONS, FUNGAL; FEMALE; FUSARIUM; HUMANS; KERATITIS; MALE; MIDDLE AGED; PYRIMIDINES; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE; TRIAZOLES; VISUAL ACUITY; YOUNG ADULT;

EID: 84875231128     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0b013e318254a41b     Document Type: Review

References (22)

1. Gower EW, Keay LJ, Oechsler RA, et al. Trends in fungal keratitis in the United States, 2001 to 2007. Ophthalmology. 2010; 117:2263-2267.
2. Saha R, Das S. Mycological profile of infectious keratitis from Delhi. Indian J Med Res. 2006; 123:159-164.
3. Gopinathan U, Garg P, Fernandes M, et al. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea. 2002; 21:555-559.
4. Shokohi T, Nowroozpoor-Dailami K, Moaddel-Haghighi T. Fungal keratitis in patients with corneal ulcer in Sari, Northern Iran. Arch Iran Med. 2006; 9:222-227.
5. Leck AK, Thomas PA, Hagan M, et al. Aetiology of suppurative corneal ulcers in Ghana and south India, and epidemiology of fungal keratitis. Br J Ophthalmol. 2002; 86:1211-1215.
6. Shukla PK, Kumar M, Keshava GB. Mycotic keratitis: an overview of diagnosis and therapy. Mycoses. 2008; 51:183-199.
7. Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol. 2008; 92:871-878.
8. Prakash G, Sharma N, Goel M, et al. Evaluation of intrastromal injection of voriconazole as a therapeutic adjunctive for the management of deep recalcitrant fungal keratitis. Am J Ophthalmol. 2008; 146:56-59.
9. Al-Badriyeh D, Neoh CF, Stewart K, et al. Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis. Clin Ophthalmol. 2010; 4:391-405.
10. Marangon FB, Miller D, Giaconi JA, et al. In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens. Am J Ophthalmol. 2004; 137:820-825.
11. Hariprasad SM, Mieler WF, Holz ER, et al. Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans. Arch Ophthalmol. 2004; 122:42-47.
12. Klont R, Eggink C, Rijs A, et al. Successful treatment of Fusarium keratitis with cornea transplantation and topical and systemic voriconazole. Clin Infect Dis. 2005; 40:e110-e112.
13. Sony P, Sharma N, Vajpayee RB, et al. Therapeutic keratoplasty for infectious keratitis: a review of the literature. CLAO J. 2002; 28:111-118.
14. Foster RK. The role of excisional keratoplasty in microbial keratitis. In: Cavanagh HD, ed. The Cornea Transactions of World Congress on the Cornea. 3rd ed. New York, NY: Raven; 1988:198.
15. Bharathi MJ, Ramakrishnan R, Vasu S, et al. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol. 2003; 51:315-321.
16. Mitsui Y, Hanabusa J. Corneal infections after cortisone therapy. Br J Ophthalmol. 1955; 39:244-250.
17. Jhanji V, Sharma N, Mannan R, et al. Management of tunnel fungal infection with voriconazole. J Cataract Refract Surg. 2007; 33:915-917.
18. Miedziak A, Miller MR, Rapuano C, et al. Risk factors in microbial keratitis leading to penetrating keratoplasty. Ophthalmology. 1999; 106:1166-1170.
19. Jhanji V, Yohendran J, Constantinou M, et al. Scedosporium scleritis or keratitis or both: case series. Eye Contact Lens. 2009; 35:312-315.
20. Lalitha P, Prajna NV, Kabra A, et al. Risk factors for treatment outcome in fungal keratitis. Ophthalmology. 2006; 113:526-530.
21. Ramsay A, Lightman S. Hypopyon uveitis [Review]. Surv Ophthalmol. 2001; 46:1-18.
22. Prajna NV, Mascarenhas J, Krishnan T, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Arch Ophthalmol. 2010; 128:672-678.